Trexquant Investment’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,016
| Closed | -$135K | – | 1695 |
|
|
2021
Q3 | $135K | Sell |
3,016
-352
| -10% | -$15.8K | 0.01% | 1021 |
|
|
2021
Q2 | $184K | Buy |
3,368
+1,665
| +98% | +$91K | 0.02% | 933 |
|
|
2021
Q1 | $127K | Sell |
1,703
-258
| -13% | -$19.2K | 0.01% | 1034 |
|
|
2020
Q4 | $213K | Buy |
+1,961
| New | +$213K | 0.02% | 864 |
|
|
2020
Q1 | – | Sell |
-1,335
| Closed | -$92K | – | 1481 |
|
|
2019
Q4 | $92K | Buy |
+1,335
| New | +$92K | 0.01% | 983 |
|
|
2019
Q1 | – | Sell |
-4,159
| Closed | -$232K | – | 1374 |
|
|
2018
Q4 | $232K | Buy |
+4,159
| New | +$232K | 0.01% | 865 |
|
|
2017
Q4 | – | Sell |
-1,914
| Closed | -$282K | – | 1293 |
|
|
2017
Q3 | $282K | Buy |
+1,914
| New | +$282K | 0.07% | 487 |
|